Share This Page
Drug Price Trends for NDC 72241-0008
✉ Email this page to a colleague
Average Pharmacy Cost for 72241-0008
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FLUOXETINE HCL 20 MG CAPSULE | 72241-0008-11 | 0.03216 | EACH | 2025-03-19 |
| FLUOXETINE HCL 20 MG CAPSULE | 72241-0008-05 | 0.03216 | EACH | 2025-03-19 |
| FLUOXETINE HCL 20 MG CAPSULE | 72241-0008-05 | 0.03107 | EACH | 2025-02-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 72241-0008
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| No data available in table | |||||||
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 72241-0008: Celecoxib Capsules
The pharmaceutical industry is constantly evolving, with market dynamics, regulatory changes, and technological advancements shaping its future. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug associated with National Drug Code (NDC) 72241-0008, which corresponds to Celecoxib capsules.
Understanding NDC 72241-0008: Celecoxib Capsules
NDC 72241-0008 is associated with Celecoxib capsules, a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation[1]. Celecoxib is commonly prescribed for conditions such as arthritis, acute pain, and menstrual cramps. As a COX-2 inhibitor, it offers pain relief with potentially fewer gastrointestinal side effects compared to traditional NSAIDs.
Manufacturer and Packaging Details
The NDC code 72241-0008 indicates that the drug is manufactured by Modavar Pharmaceuticals LLC[1]. This specific NDC is part of a family of Celecoxib products with various strengths and package sizes, including:
- 72241-022-03
- 72241-022-11
- 72241-023-03
- 72241-023-05
- 72241-023-10
- 72241-023-11
- 72241-024-03
- 72241-024-05
- 72241-024-10
- 72241-024-11
- 72241-025-03
- 72241-025-20
Current Market Trends in the Pharmaceutical Industry
To understand the potential price projections for Celecoxib capsules, it's crucial to examine the broader pharmaceutical market trends.
Overall Market Growth
The US pharmaceutical market is on a trajectory of significant growth. Projections indicate an expansion from $846.72 billion in 2022 to an impressive $1.28 trillion by 2030, representing a Compound Annual Growth Rate (CAGR) of 5.36%[3].
Specialty Pharmaceuticals Driving Growth
Specialty pharmaceuticals, which include drugs treating complex or chronic conditions, are a major driver of market growth. These medications are expected to see a price increase of 4.18% in 2024[2].
Vizient, Inc. projects drug price inflation to grow at 3.8% in the latest Pharmacy Market Outlook. Driven in part by specialty pharmacy, including the increasing utilization of weight loss drugs, it is the highest projected increase since July 2019.[6]
Biosimilars: A Growing Market Segment
Biosimilars are gaining market share and are anticipated to play a significant role in reducing overall costs. While their price increase is projected to be modest at 0.55%, their increasing prevalence is expected to impact the broader market[2].
Price Projections for Celecoxib Capsules (NDC 72241-0008)
While specific price projections for NDC 72241-0008 are not available without detailed information about the drug product itself, we can infer several implications based on market trends and the nature of the drug.
Impact of Overall Market Trends
Given the projected 3.8% increase in drug prices for 2024, it's reasonable to expect that Celecoxib capsules may see a similar price adjustment[6]. However, as Celecoxib is not a specialty pharmaceutical, its price increase may be more modest compared to the 4.18% projected for specialty drugs.
Generic Status Considerations
Celecoxib is available as a generic drug, which typically means lower prices and slower price increases compared to brand-name medications. The presence of multiple manufacturers in the market can help keep prices competitive.
Supply Chain and Manufacturing Costs
Increases in manufacturing costs, potential drug shortages, and challenges in the supply chain could drive up prices. In 2023, hospitals experienced significant challenges due to drug shortages and rising costs, which could impact the pricing of specific drugs like Celecoxib[2].
Factors Influencing Celecoxib Pricing
Several key factors will influence the pricing of Celecoxib capsules in the coming years:
Regulatory Compliance
As with all pharmaceutical products, Celecoxib must comply with FDA regulations. This includes proper listing in the NDC Directory, ensuring that the product meets safety and effectiveness standards[1][4].
Market Competition
The presence of multiple manufacturers producing generic Celecoxib can help keep prices competitive. However, any consolidation in the market or supply chain issues affecting multiple manufacturers could lead to price increases.
Healthcare Policy Changes
Potential changes in healthcare policy, such as the implementation of Medicare's drug price negotiation program, could significantly impact pricing dynamics for drugs like Celecoxib[5].
Technological Advancements
The adoption of AI-based tools in drug discovery and development is expected to increase R&D expenditures but could also lead to more efficient and cost-effective drug development processes in the long run[3]. This could potentially impact the pricing of drugs like Celecoxib in the future.
Immunology and Inflammation Sector Growth
While Celecoxib is not specifically an immunology drug, it's worth noting the growth in the immunology and inflammation (I&I) sector, as it may indirectly impact the market for pain and inflammation medications.
The global immunology market is projected to grow from $103.18 billion in 2024 to $257.39 billion by 2032, exhibiting a CAGR of 12.1% during the forecast period.[7]
This growth in the I&I sector could lead to increased research and development in pain and inflammation treatments, potentially introducing new competitors or improved formulations that could impact the market for Celecoxib.
Political Landscape and Its Potential Impact
The political landscape, particularly in the United States, could play a significant role in shaping the pharmaceutical market, including the pricing of drugs like Celecoxib.
Potential Policy Changes
With the upcoming change in administration, there may be shifts in healthcare policies that could affect drug pricing. For instance, potential changes in drug pricing regulations or healthcare reform could have far-reaching impacts on the pharmaceutical industry[7].
Medicare Drug Price Negotiation
The implementation of Medicare's drug price negotiation program, set to begin in 2026, could significantly impact the pricing landscape. While initial negotiations focus on high-cost drugs, the program's expansion could eventually affect a broader range of medications, potentially including generic drugs like Celecoxib[5].
Market Outlook for Celecoxib Capsules
Considering all these factors, the market outlook for Celecoxib capsules (NDC 72241-0008) is cautiously optimistic. While the overall pharmaceutical market is projected to grow, the generic status of Celecoxib may help keep its price increases more modest compared to specialty drugs.
Potential Price Scenarios
-
Modest Increase: In line with overall market trends, Celecoxib prices may see a modest increase, potentially in the 2-3% range annually.
-
Stable Pricing: Strong competition in the generic market could lead to relatively stable pricing for Celecoxib.
-
Potential Decreases: If new competitors enter the market or if there are significant policy changes favoring lower drug prices, we could potentially see price decreases for Celecoxib.
Strategies for Stakeholders
Given the complex market dynamics, various stakeholders in the Celecoxib market should consider the following strategies:
For Manufacturers
- Invest in efficient production processes to maintain competitive pricing
- Monitor regulatory changes and adapt quickly to new requirements
- Explore partnerships or mergers to strengthen market position
For Healthcare Providers
- Stay informed about pricing trends and alternative treatment options
- Consider bulk purchasing agreements to secure favorable pricing
- Educate patients about generic options like Celecoxib
For Patients
- Discuss generic options with healthcare providers
- Stay informed about patient assistance programs
- Consider long-term prescriptions if appropriate to potentially lock in current prices
Key Takeaways
-
The pharmaceutical market is projected to grow significantly, with a 3.8% overall price increase expected in 2024.
-
Celecoxib, as a generic medication, may see more modest price increases compared to specialty pharmaceuticals.
-
Factors such as regulatory changes, market competition, and technological advancements will play crucial roles in determining future pricing for Celecoxib.
-
The implementation of Medicare's drug price negotiation program could have far-reaching effects on drug pricing, potentially including generic drugs like Celecoxib.
-
Stakeholders should stay informed about market trends and be prepared to adapt to changing conditions in the pharmaceutical landscape.
FAQs
-
Q: What is the current market size for Celecoxib? A: While specific market size for Celecoxib is not provided in the available information, the overall US pharmaceutical market is projected to reach $1.28 trillion by 2030.
-
Q: How might the upcoming political changes affect Celecoxib pricing? A: Political changes could lead to new healthcare policies and regulations that may impact drug pricing. However, the exact effects on Celecoxib pricing remain uncertain and will depend on specific policy implementations.
-
Q: Are there any upcoming patent expirations that could affect the Celecoxib market? A: Celecoxib is already available as a generic drug, so there are no immediate patent expirations that would significantly alter its market dynamics.
-
Q: How does the growth in the immunology and inflammation sector relate to Celecoxib? A: While Celecoxib is not an immunology drug, the growth in the I&I sector could lead to increased research in pain and inflammation treatments, potentially introducing new competitors or improved formulations that could impact the Celecoxib market.
-
Q: What role might AI play in the future pricing of drugs like Celecoxib? A: AI-based tools in drug discovery and development could lead to more efficient and cost-effective processes, potentially impacting the pricing of drugs like Celecoxib in the long term.
Sources cited: [1] https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0f73074-f3d8-4812-8e64-f88a02869ed3 [2] https://www.drugpatentwatch.com/p/drug-price/ndc/82009-0008 [3] https://www.pwc.com/us/en/industries/pharma-life-sciences/pharmaceutical-industry-trends.html [5] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information [6] https://www.vizientinc.com/newsroom/news-releases/2024/vizient-projects-3-8-drug-price-increase-driven-by-specialty-pharmaceuticals [7] https://www.labiotech.eu/in-depth/biotech-trends-2025/
More… ↓
